Write your message
Volume 7, Issue 6 (November - December 2022)                   J Obstet Gynecol Cancer Res 2022, 7(6): 583-586 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ashraf Ganjoei T, Talayeh M, Afsharmoghadam N, Norouzi A R, Noei Teymoordash S. Serous Borderline Tumor of the Fallopian Tube: A Case Report and Literature Review. J Obstet Gynecol Cancer Res. 2022; 7 (6) :583-586
URL: http://jogcr.com/article-1-509-en.html
1- Department of Gynaeco-Oncology, Preventative Gynecology Research Center, Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2- Department of Pathology, Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3- Pediatric Respiratory Diseases Research Center (PRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Masih Daneshvari Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4- Department of Obstetrics and Gynecology, Firoozgar Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran , noeiteymoordash.s@iums.ac.ir
Abstract:   (150 Views)

Paratubal cysts account for 5-20% of all adnexal lesions. Malignant modifications seldom arise in the paratubal cysts that are usually known as primary carcinomas of fallopian tube. Paratubal borderline tumors are very infrequent conditions and until now only sixteen cases of primary paratubal borderline tumors have been previously reported in the literature. Herein, we describe a rare paratubal serous borderline tumor occurring in a woman of reproductive age and provide insights into its management. A 32-year-old woman referred to Imam Hussein Hospital, Tehran with chief complaint of amenorrhea for the last year and transvaginal sonography (TVS) report indicating a 68×74 mm persistent right adnexal cyst from 10 months ago. The patient was candidate for laparotomy and due to the report of paratubal serous borderline tumor in frozen section she underwent right total salpingectomy and infracolic omentectomy. No evidence of recurrence or metastasis was observed after 3 years of follow up. Persistent adnexal cysts need to be evaluated precisely even in young women in order to rule out the malignancy of fallopian tubes.

     
Systematic Review: Case Report | Subject: Gynecology Oncology
Received: 2021/10/2 | Accepted: 2022/04/6 | Published: 2022/09/9

References
1. Seamon LG, Holt CN, Suarez A, Richardson DL, Carlson MJ, O'Malley DM. Paratubal borderline serous tumors. Gynecol Oncol. 2009;113(1):83-5. [DOI:10.1016/j.ygyno.2008.12.019] [PMID]
2. Zheng W, Wolf S, Kramer EE, Cox KA, Hoda SA. Borderline papillary serous tumour of the fallopian tube. Am J Surg Pathol. 1996;20(1):30-5. [DOI:10.1097/00000478-199601000-00003] [PMID]
3. Noei Teymoordash S, Arab M, Afsharmoghadam N, Nouri B, Jahed bozorgan T, Talayeh M. A Rare Case of Late Recurrence in Pseudomyxoma Peritonei and Advanced Stage of Borderline Mucinous Ovarian Tumor. J Obstet Gynecol Cancer Res. 2020;5(3):103-9. [DOI:10.30699/jogcr.5.3.103]
4. Villella JA, Pauli SA, Wang J, Intengan M, Lele S. Tumors of low malignant potential arising in the fallopian tube: case reports. Eur J Gynaecol Oncol. 2005;26(3):327-9.
5. Zvizdic Z, Bukvic M, Murtezic S, Skenderi F, Vranic S. Giant Paratubal Serous Cystadenoma in an Adolescent Female: Case Report and Literature Review. J Pediatr Adolesc Gynecol. 2020;33(4):438-40. [DOI:10.1016/j.jpag.2020.03.010] [PMID]
6. Shin YJ, Kim JY, Lee HJ, Park JY, Nam JH. Paratubal serous borderline tumor. J Gynecol Oncol. 2011;22(4):295-8. [DOI:10.3802/jgo.2011.22.4.295] [PMID] [PMCID]
7. Zheng W, Wolf S, Kramer EE, Cox KA, Hoda SA. Borderline Papillary Serous Tumor of the Fallopian Tube. The American Journal of Surgical Pathology. 1996;20(1):30-5. [DOI:10.1097/00000478-199601000-00003] [PMID]
8. Kayaalp E, Heller DS, Majmudar B. Serous tumor of low malignant potential of the fallopian tube. Int J Gynecol Pathol. 2000;19(4):398-400. [DOI:10.1097/00004347-200010000-00019] [PMID]
9. Haratz-Rubinstein N, Fromberg E, Lederman S. Sonographic diagnosis of a serous tumor of low malignant potential of the fallopian tube. J Ultrasound Med. 2004;23(6):869-72. [DOI:10.7863/jum.2004.23.6.869] [PMID]
10. Krasevic M, Stankovic T, Petrovic O, Smiljan-Severinski N. Serous borderline tumor of the fallopian tube presented as hematosalpinx: a case report. BMC Cancer. 2005;5(1):129. [DOI:10.1186/1471-2407-5-129] [PMID] [PMCID]
11. Kumbak B, Celik H, Cobanoglu B, Gurates B. Paratubal borderline tumor incidentally found during cesarean section: case report and review of literature. Eur J Surg Oncol. 2010;36(8):789-91. [DOI:10.1016/j.ejso.2010.06.019] [PMID]
12. Stephens D, Pillai S, Cham E, Arensman R, Chou P. Serous borderline tumor of the fallopian tube in a patient with Klippel-Trenaunay syndrome. J Pediatr Surg. 2010;45(11):2244-6. [DOI:10.1016/j.jpedsurg.2010.06.043] [PMID]
13. Abreu R, Dick M, Simoes Silva T, Mota F, Bettencourt E. Serous borderline tumor of the fallopian tube presented as an adnexal mass. Arch Gynecol Obstet. 2011;283(2):349-52. [DOI:10.1007/s00404-010-1410-8] [PMID]
14. Ondic O, Kalis V, Sima R. Borderline papillary serous tumor of the fimbriated end of the fallopian tube with peritoneal implants. J Obstet Gynaecol Res. 2011;37(11):1702-5. [DOI:10.1111/j.1447-0756.2011.01556.x] [PMID]
15. Choi SM, Choi MY, Kang WD, Choi HS, Kim SM. Serous borderline tumor of the fallopian tube. Obstet Gynecol Sci. 2014;57(4):334-7. [DOI:10.5468/ogs.2014.57.4.334] [PMID] [PMCID]
16. Baek J. Paratubal borderline serous tumor in a postmenopausal woman: a case report. Pan Afr Med J. 2019;32:129. [DOI:10.11604/pamj.2019.32.129.18031] [PMID] [PMCID]
17. Mehawej J, El Helou N, Wang L, Mhawech-Fauceglia P. Paratubal serous borderline tumor in an 85 years old woman: A case report. Gynecol Oncol Rep. 2020;32:100559. [DOI:10.1016/j.gore.2020.100559] [PMID] [PMCID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jogcr.com/.

© 2022 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.